Antihyperglycemic activity of novel naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides.
J W Ellingboe, L J Lombardo, T R Alessi, T T Nguyen, F Guzzo, C J Guinosso, J Bullington, E N Browne, J F Bagli, J Wrenn
Index: J. Med. Chem. 36(17) , 2485-93, (1993)
Full Text: HTML
Abstract
A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. Substitution at the 1-, 5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4-[(5-Chloronaphthalen-2-yl)methyl]-3H-1,2,3,5-oxathiadiazole++ + 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.
Related Compounds
Related Articles:
Birch Reduction of 2-Naphthoic and of ortho-Methoxynaphthoic Acids. Eliel EL and Hoover TE.
[J. Org. Chem. 24(7) , 938-942, (1959)]
Extraction and spectrophotometric determination of vanadium (V) with N-[p-(N, N-dimethylanilino)-3-methoxy-2-naphtho] hydroxamic acid. Abbasi S.
[Anal. Chem. 48(4) , 714-717, (1976)]
Studies in metal-ammonia reduction-5: Reduction and reductive methylation of some naphthoic acids. Murthy AR, et al.
[Tetrahedron 38(18) , 2831-2836, (1982)]